Intra-Cellular Therapies Reports Completion of Enrollment of ITI-007-302 Phase 3 Clinical Trial for the Treatment of Schizophrenia

News
1

http://ir.intracellulartherapies.com/releasedetail.cfm?ReleaseID=977746

5 Likes
2

Man I hope this gets released in Europe.

3

It’s only a 6 week trial. So maybe it could get released next year in the states, and then 2057 in Europe. :smile:

1 Like
4

I hope not, but niece joke :smile:

5

Lol! You’re funny!

1 Like
6

Wow this whole time and they havent even started yet? Jesus

2 Likes
7

It looks like it is pretty advanced…I hope it’s out for when my current med craps out. I just don’t trust atypicals, they seem to crap out sooner or later. But I can’t do my lifestyle on typicals, they’re too sedating and I just will not participate in being fat.

8

I still think it’s funny that they snuck 007 into it’s name!

1 Like
9

So the trial should be complete in 6 weeks. That is good news that progress is being made.

Then they have to collect, analyze and publish the results. That will take months.
If the results are good, then they have to prepare an application to the FDA. That takes months.
The FDA reviews and hopefully approves the application in 5-9 months after submission.

1 Like
10

So disappointed…thought it would be sooner🙁

1 Like
11

I hope it turns out as good as the hype so far suggests. And I hope I’m not allergic to it or something.

12

I’m waiting for it’s first black box warnings!

So I’ll probably wait a few yrs of it coming out before I try it!

1 Like